Skip to main content
. Author manuscript; available in PMC: 2022 Aug 17.
Published in final edited form as: Minim Invasive Ther Allied Technol. 2017 Apr 18;26(6):331–337. doi: 10.1080/13645706.2017.1310737

Table 4.

Sub-analysis of changes in CTL, Treg, and CTL/Treg ratio in each parameter.

Parameter Patient no. CTL Treg CTL/Treg ratio
Baseline After treatment p Value Baseline After treatment p Value Baseline After treatment p Value
Age (years) 8
 ≦60 11 27.6 ± 2.7 31.2 ± 2.9 .10 2.6 ± 0.5 2.4 ± 0.6 .52 15.9 ± 5.3 19.2 ± 4.2 .33
 >60 27.4 ± 3.2 29.5 ± 3.9 .24 1.8 ± 0.3 1.6 ± 0.2 .43 20.9 ± 5.2 23.3 ± 5.5 .14
Gender
 Male 10 30.8 ± 2.9 34.7 ± 3.4 .10 1.8 ± 0.3 1.5 ± 0.2 .17 23.4 ± 5.5 28.2 ± 5.7 <.02
 Female 9 23.9 ± 2.8 25.2 ± 3.1 .22 2.6 ± 0.5 2.5 ± 0.6 .78 13.7 ± 4.4 14.3 ± 2.8 .82
Primary diagnosis
 Colorectal 8 22.6 ± 2.5 24.5 ± 3.5 .43 2.4 ± 0.3 2.2 ± 0.4 .54 11.6 ± 3.4 15.7 ± 4.3 .06
 Soft tissue 8 28.5 ± 2.4 32.1 ± 2.9 .12 2.1 ± 0.5 2.0 ± 0.5 .75 19.4 ± 4.5 20.3 ± 2.8 .79
 Lung 2
 Gynecologic 1
Target tumor
 Primary 3 27.5 ± 2.1 30.2 ± 2.5 .21 2.1 ± 0.3 1.9 ± 0.3 .11 18.8 ± 3.7 21.6 ± 3.6 .54
 Metastasis 16 25.9 ± 2.3 28.5 ± 2.8 .09 2.1 ± 0.2 1.8 ± 0.2 .21 16.7 ± 3.7 20.7 ± 3.9 <.02
Ablation site
 Lung 7 27.9 ± 4.6 32.0 ± 5.3 .07 1.8 ± 0.3 1.9 ± 0.5 .71 23.2 ± 7.2 28.1 ± 7.9 <.05
 Soft tissue 5 26.7 ± 2.7 31.1 ± 3.6 .13 3.5 ± 0.5 2.6 ± 0.8 .06 7.9 ± 0.8 14.4 ± 2.2 <.03
 Liver 4 25.7 ± 2.2 29.4 ± 5.8 .51 1.9 ± 0.2 1.7 ± 0.3 .60 13.9 ± 2.0 17.8 ± 4.4 .26
 Bone 3 31.3 ± 3.9 30.2 ± 4.0 .20 1.0 ± 0.2 1.3 ± 0.2 .11 32.0 ± 6.4 24.4 ± 2.5 .19
Target tumor number
 Single 16 27.1 ± 2.1 30.6 ± 2.9 .05 2.2 ± 0.4 2.0 ± 0.4 .39 18.3 ± 3.8 20.3 ± 3.5 .35
 2 or 3 3 28.4 ± 5.4 29.4 ± 5.3 .59 2.1 ± 0.3 1.8 ± 0.6 .59 19.9 ± 8.9 24.5 ± 8.9 .12
Maximum diameter of target tumor (cm)
 ≦2 13 24.4 ± 1.9 28.4 ± 2.8 .35 2.1 ± 0.3 1.9 ± 0.3 .82 15.5 ± 3.1 19.5 ± 3.4 .06
 >2 6 34.1 ± 4.6 34.2 ± 5.2 .94 2.3 ± 0.7 2.0 ± 0.7 .44 25.9 ± 9.4 26.1 ± 9.0 .96
Ablation technique
 Heat-based ablation 14 26.6 ± 2.7 29.0 ± 3.0 .13 2.1 ± 0.3 1.9 ± 0.3 .39 18.0 ± 4.4 21.6 ± 4.7 <.02
 Cryoablation 5 29.9 ± 3.2 33.7 ± 4.6 .24 2.3 ± 0.8 2.1 ± 0.9 .66 21.0 ± 7.0 21.5 ± 4.3 .92
Ablative zone area (cm2)
 ≦10 11 25.5 ± 2.1 29.3 ± 3.3 .08 2.4 ± 0.4 2.2 ± 0.4 .32 14.5 ± 3.1 17.4 ± 3.3 .09
 >10 8 30.2 ± 4.1 31.5 ± 4.1 .38 4.5 ± 0.5 3.9 ± 0.6 .65 24.8 ± 7.3 27.5 ± 7.0 .43

Data are presented as mean and standard error (SE).

CTL: cytotoxic T-lymphocyte; Treg: regulatory T-cell.